Corrigendum to GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9-mediated Genome Editing (Molecular Therapy - Nucleic Acids (2016) 5 (e334) (S2162253117300616) (10.1038/mtna.2016.48))

Astrid Glaser, Bradley McColl, Jim Vadolas

Research output: Contribution to journalComment / DebateOtherpeer-review


Molecular Therapy–Nucleic Acids (2016) 5, e360; doi:10.1038/mtna.2016.78; published online 13 September 2016 Correction to: Molecular Therapy–Nucleic Acids (2016) 5, e334; doi:10.1038/mtna.2016.48; published online 12 July 2016 Following publication, the authors noted that a single nucleotide depicting the EGFP sequence in Figure 1b 1c was missing. Furthermore, in order to keep the length of the homology arms constant, ssODN2 is 7nt longer than ssODN1, which was not stated in the figure legend. The corrected Figure 1 and legend appear below. In addition, the complete oligonucleotide sequences used in this study are now included in the Supplementary Materials and Methods, attached as supplementary material to this corrigendum. The authors apologize for these omissions and any confusion they may have caused. Supplementary Material: [Figure presented]

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalMolecular Therapy - Nucleic Acids
Publication statusPublished - 1 Jan 2016
Externally publishedYes

Cite this